Your best medicine news resource
Oct 13th 2008Drug InformationIrritable-Bowel Syndrome
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced findings from two analyses of a Phase II clinical trial that demonstrate the utility of rifaximin, a non-absorbed, gut-selective antibiotic, in the treatment of patients with diarrhea-predominant irritable bowel syndrome (IBS).
More: continued here
Oct 13th 2008Drug InformationIrritable-Bowel Syndrome
Several studies presented at the American College of Gastroenterology’s 73rd Annual Scientific Meeting in Orlando highlight the safety and efficacy of probiotics in improving symptoms and normalizing bowel movement frequency in patients suffering from constipation or diarrhea related to Irritable Bowel Syndrome (IBS).
More: continued here
Oct 1st 2008Drug InformationIrritable-Bowel Syndrome
Boston University School of Medicine (BUSM) will present The Seventh Annual Sue Kim Hanson Lecture in Immunology on Friday, September 12, 2008 at noon in the School’s Keefer Auditorium. The annual lecture is in honor of Sue Kim Hanson, MA, PhD ‘02, a former researcher in BUSM’s Pulmonary Center. Kim Hanson, along with her husband and daughter, were passengers on United Airline flight 175, the second plane that struck the World Trade Center on September 11, 2001.
More: continued here
Your best medicine news resource
